EDIT:NASDAQ
Editas Medicine Inc
2,17 US$
arrow_upward
+1,40%(+0,030) 1K
13-noy, 16:00:01 (GMT-5) · USD
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoEDIT tikeri uchun statistika yaratilmoqda...
Ochish
2,14 US$
Yuqori
2,21 US$
Past
2,01 US$
Bozor kapitali
334,92 mln
Oʻrtacha hajm
2,42 mln
Hajmi
2,79 mln
52 haftalik eng yuqori
3,94 US$
52 haftalik eng past
1,66 US$
Aksiya boʻyicha daromad
-0,62 US$
Beta
2,09
Muomaladagi aksiyalar
154,34 mln
Xodimlar soni
87
Ochish
2,14 US$
Yuqori
2,21 US$
Past
2,01 US$
Bozor kapitali
334,92 mln
Oʻrtacha hajm
2,42 mln
Hajmi
2,79 mln
52 haftalik eng yuqori
3,94 US$
52 haftalik eng past
1,66 US$
Aksiya boʻyicha daromad
-0,62 US$
Beta
2,09
Muomaladagi aksiyalar
154,34 mln
Xodimlar soni
87
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
Seeking Alpha
·
55 daqiqa oldin
S&P 500: It's Not Over, What To Expect In Chapter Two Of This Correction (Technical Analysis)
Foreign Policy Journal
·
1 soat oldin
Trump Media (NASDAQ: DJT) Faces Billion-Dollar Reckoning As Crypto Strategy Unravels And Cash Reserves Fall Short
TheStreet
·
2 soat oldin
Berkshire’s record high exposes hidden trap in S&P 500 401(k) plans
Bloomberg.com
·
1 kun oldin
SpaceX’s S&P 500 Bid Gets New Life as Musk Pitches Tesla Merger
Profil
Editas Medicine, Inc., is a clinical-stage biotechnology company that is developing therapies for rare diseases using CRISPR gene editing technology. Editas Medicine headquarters is located in Cambridge, Massachusetts with additional facilities in Boulder, Colorado. Wikipedia
Editas Medicine Inc haqida
CEO-
Xodimlar soni87
Asos solingannoy 2013
Bosh ofislar-
SektorHealth Care
Soha-
Veb-sayteditasmedicine.com